BR9714010A - Triparredoxina, plasmìdeo de expressão, processo para produção, uso, sistema de teste e preparado farmacêutico - Google Patents

Triparredoxina, plasmìdeo de expressão, processo para produção, uso, sistema de teste e preparado farmacêutico

Info

Publication number
BR9714010A
BR9714010A BR9714010-4A BR9714010A BR9714010A BR 9714010 A BR9714010 A BR 9714010A BR 9714010 A BR9714010 A BR 9714010A BR 9714010 A BR9714010 A BR 9714010A
Authority
BR
Brazil
Prior art keywords
production
test system
pharmaceutical preparation
triparredoxin
expression plasmid
Prior art date
Application number
BR9714010-4A
Other languages
English (en)
Inventor
Leopold Flohe
Everson Nogeceke
Henryk Kalisz
Marisa Montemartini
Original Assignee
Leopold Flohe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leopold Flohe filed Critical Leopold Flohe
Publication of BR9714010A publication Critical patent/BR9714010A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Patente de Invenção: <B>''TRIPARREDOXINA, PLASMìDEO DE EXPRESSãO, PROCESSO PARA PRODUçãO, USO, SISTEMA DE TESTE E PREPARADO FARMACêUTICO''<D>. A presente invenção refere-se a novas enzimas, triparredoxinas, seu isolamento a partir de <MU>Crithidia fasciculata<MV>, a um método para a produção das mesmas em bactérias geneticamente transformadas e seu uso como alvos moleculares para a constatação de drogas tripanocidas.
BR9714010-4A 1996-12-12 1997-12-12 Triparredoxina, plasmìdeo de expressão, processo para produção, uso, sistema de teste e preparado farmacêutico BR9714010A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96120015 1996-12-12
PCT/EP1997/006983 WO1998026051A2 (en) 1996-12-12 1997-12-12 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation

Publications (1)

Publication Number Publication Date
BR9714010A true BR9714010A (pt) 2000-05-09

Family

ID=8223490

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714010-4A BR9714010A (pt) 1996-12-12 1997-12-12 Triparredoxina, plasmìdeo de expressão, processo para produção, uso, sistema de teste e preparado farmacêutico

Country Status (10)

Country Link
US (3) US6432671B1 (pt)
EP (1) EP0944718A2 (pt)
JP (1) JP2001505773A (pt)
KR (1) KR20000069395A (pt)
AU (1) AU746917B2 (pt)
BR (1) BR9714010A (pt)
CA (1) CA2275175A1 (pt)
IL (1) IL130272A0 (pt)
NZ (1) NZ335968A (pt)
WO (1) WO1998026051A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000069395A (ko) * 1996-12-12 2000-11-25 프로헤 레오폴드 트리파레독신, 발현 플라스미드, 제조방법, 용도, 시험 시스템및 의약 제제
US20030228294A1 (en) * 2002-04-08 2003-12-11 The John Hopkins University Inhibition of tumor growth via peroxiredoxin 3
DE602004022929D1 (de) * 2003-03-31 2009-10-15 Novozymes Inc Verfahren zur produktion biologischer substanzen i
EP1841879A4 (en) * 2005-01-25 2009-05-27 Population Genetics Technologi ISOTHERMAL DNA AMPLIFICATION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942170A (en) * 1988-05-27 1990-07-17 The Rockefeller University 2-(substituted methylidene)-N-[3-[piperidin-1-yl]propyl]hydrazine carboximidamides useful as antiparasitics
KR20000069395A (ko) * 1996-12-12 2000-11-25 프로헤 레오폴드 트리파레독신, 발현 플라스미드, 제조방법, 용도, 시험 시스템및 의약 제제

Also Published As

Publication number Publication date
EP0944718A2 (en) 1999-09-29
US6432671B1 (en) 2002-08-13
KR20000069395A (ko) 2000-11-25
US20050143559A1 (en) 2005-06-30
AU5856398A (en) 1998-07-03
US20030082202A1 (en) 2003-05-01
WO1998026051A2 (en) 1998-06-18
CA2275175A1 (en) 1998-06-18
IL130272A0 (en) 2000-06-01
AU746917B2 (en) 2002-05-02
JP2001505773A (ja) 2001-05-08
WO1998026051A3 (en) 1998-11-19
NZ335968A (en) 2000-12-22

Similar Documents

Publication Publication Date Title
US5872104A (en) Combinations and methods for reducing antimicrobial resistance
Ciaston et al. Proteolytic activity-independent activation of the immune response by gingipains from Porphyromonas gingivalis
IL112664A0 (en) 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
AU6002696A (en) Method of producing a solid dispersion of a poorly water sol uble drug
FR2724384B1 (fr) Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament
BR9809791A (pt) Compostos de fosfato de aminoalquil glucosamina e seu uso como auxiliares e imuno efetores
FR2741066B1 (fr) Nouveaux agents de transfection et leurs applications pharmaceutiques
BR0013948A (pt) Prodroga, composição farmacêutica, e, método de tratamento de um paciente mamìfero
BG103969A (en) C-4&#34;-substituted macrolide derivatives
UY26372A1 (es) &#34;imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen &#34;
FR2670491B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
YU1396A (sh) 2,9-disupstituisani purin-6-oni, postupak za njihovo pripremanje i njihova primena u lekovima
SE9600716L (sv) Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
JPH01131119A (ja) 二本鎖rnaを含んで成る非経口投与剤
BRPI9915480B8 (pt) azalídeos de 13 membros, composições farmacêuticas compreendendo os mesmos, método para sua preparação bem como seus usos.
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
CN105943559A (zh) 细菌核糖核酸细胞壁组合物及其制备和使用方法
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
PT1124841E (pt) Fenil-alcenoil-guanidinas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como composicao farmaceutica que as contem
Gismondo et al. Immunostimulating effect of oral glutamine
CA2252438A1 (en) Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
BRPI0407907A (pt) derivados de ácido alcánico substituìdos com aril-cicloaquila, processos para preparação dos mesmos e uso dos mesmos como medicamentos
IT1276162B1 (it) Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
BR9714010A (pt) Triparredoxina, plasmìdeo de expressão, processo para produção, uso, sistema de teste e preparado farmacêutico

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1917 DE 02/10/2007.